Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 1
2009 2
2010 4
2011 3
2012 2
2013 4
2014 1
2015 4
2016 2
2017 4
2018 4
2019 7
2020 7
2021 5
2022 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.
Moreno L, Weston R, Owens C, Valteau-Couanet D, Gambart M, Castel V, Zwaan CM, Nysom K, Gerber N, Castellano A, Laureys G, Ladenstein R, Rössler J, Makin G, Murphy D, Morland B, Vaidya S, Thebaud E, van Eijkelenburg N, Tweddle DA, Barone G, Tandonnet J, Corradini N, Chastagner P, Paillard C, Bautista FJ, Gallego Melcon S, De Wilde B, Marshall L, Gray J, Burchill SA, Schleiermacher G, Chesler L, Peet A, Leach MO, McHugh K, Hayes R, Jerome N, Caron H, Laidler J, Fenwick N, Holt G, Moroz V, Kearns P, Gates S, Pearson ADJ, Wheatley K; Innovative Therapies for Children with Cancer (ITCC) and European Association for Neuroblastoma Research (SIOPEN). Moreno L, et al. Among authors: castellano a. J Clin Oncol. 2024 Apr 1;42(10):1135-1145. doi: 10.1200/JCO.23.00458. Epub 2024 Jan 8. J Clin Oncol. 2024. PMID: 38190578 Free article. Clinical Trial.
Histopathological Spectrum and Molecular Characterization of Liver Tumors in the Setting of Fontan-Associated Liver Disease.
Francalanci P, Giovannoni I, Tancredi C, Gagliardi MG, Palmieri R, Brancaccio G, Spada M, Maggiore G, Pietrobattista A, Monti L, Castellano A, Giustiniani MC, Onetti Muda A, Alaggio R. Francalanci P, et al. Among authors: castellano a. Cancers (Basel). 2024 Jan 11;16(2):307. doi: 10.3390/cancers16020307. Cancers (Basel). 2024. PMID: 38254797 Free PMC article.
FGFR1 is a potential therapeutic target in neuroblastoma.
Cimmino F, Montella A, Tirelli M, Avitabile M, Lasorsa VA, Visconte F, Cantalupo S, Maiorino T, De Angelis B, Morini M, Castellano A, Locatelli F, Capasso M, Iolascon A. Cimmino F, et al. Among authors: castellano a. Cancer Cell Int. 2022 Apr 29;22(1):174. doi: 10.1186/s12935-022-02587-x. Cancer Cell Int. 2022. PMID: 35488346 Free PMC article.
Tumor-infiltrating T cells and PD-L1 expression in childhood malignant extracranial germ-cell tumors.
Boldrini R, De Pasquale MD, Melaiu O, Chierici M, Jurman G, Benedetti MC, Salfi NC, Castellano A, Collini P, Furlanello C, Pistoia V, Cifaldi L, Terenziani M, Fruci D. Boldrini R, et al. Among authors: castellano a. Oncoimmunology. 2018 Dec 13;8(2):e1542245. doi: 10.1080/2162402X.2018.1542245. eCollection 2019. Oncoimmunology. 2018. PMID: 30713803 Free PMC article.
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
Dondero A, Morini M, Cangelosi D, Mazzocco K, Serra M, Spaggiari GM, Rotta G, Tondo A, Locatelli F, Castellano A, Scuderi F, Sementa AR, Eva A, Conte M, Garaventa A, Bottino C, Castriconi R. Dondero A, et al. Among authors: castellano a. J Immunother Cancer. 2021 Apr;9(4):e002293. doi: 10.1136/jitc-2020-002293. J Immunother Cancer. 2021. PMID: 33795387 Free PMC article.
49 results